secwatch / observer
8-K filed February 3, 2023, 6:59 PM ET ticker HSCS CIK 0001468492
other material confidence high sentiment neutral materiality 0.70

Heart Test Labs amends warrants to allow cashless exercise at $1.00 per share for 10 days

HeartSciences Inc.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.95

HeartSciences Inc. amended Amendment No. 2 to the Bridge Warrants with the lead investor under the SPA valued at Amendment to Bridge Warrants reducing exercise price to $1.00 for limited period (Feb 3-16, 2023), a (effective 2023-02-03).

Action
amendment
Agreement
equity purchase
Counterparty
the lead investor under the SPA
Value
Amendment to Bridge Warrants reducing exercise price to $1.00 for limited period (Feb 3-16, 2023), a
Effective
2023-02-03
Exact text from the filing
On February 3, 2023, Heart Test Laboratories, Inc. (the “Company”) entered into Amendment No. 2 (the “Amendment”) to the warrants to purchase shares of the Company’s common stock, par value $0.001 per share (“Common Stock”), issued in the Company’s private placement of securities pursuant to that certain Securities Purchase Agreement dated as of December 22, 2021 (the “SPA,” and such warrants issued thereunder, as previously amended on September 8, 2022, the “Bridge Warrants”).
View on SEC.gov

Browse all material agreements →

HeartSciences Inc. filing history →

Source: SEC EDGAR
accession 0000950170-23-001791
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.